Digitek Manufacturer to Remain Shut Down After Recall
The U.S. Department of Justice (DOJ) and the Food and Drug Administration (FDA) are taking steps to keep barring drugmaker Actavis Totowa from manufacturing or distributing generic drugs in the United States. Actions were taken after a series of manufacturing incidents that resulted in a nationwide Digitek recall in early 2008 when double strength pills were produced. A subsequent recall involved potential issues with over 65 different generic drugs. On November 14 2008, the Justice Department announced that the United States…
Topics: Actavis Totowa, Digitek, fda, Food and Drug Administration, generic drugs, justice, Justice Department, lawsuit, manufacturer, Nationwide, recall, state, sue